cyproterone - CISMeF

Preferred Label : cyproterone;

MeSH definition : An anti-androgen that, in the form of its acetate (CYPROTERONE ACETATE), also has progestational properties. It is used in the treatment of hypersexuality in males, as a palliative in prostatic carcinoma, and, in combination with estrogen, for the therapy of severe acne and hirsutism in females.;

MeSH hyponym : cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer;

MeSH CAS label : 3'H-Cyclopropa(1,2)pregna-1,4,6-triene-3,20-dione, 6-chloro-1,2-dihydro-17-hydroxy-, (1beta,2beta)-;

MeSH Related Number : cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer; 2098-66-0 (Cyproterone); 34554-28-4 (1 alpha,2 alpha,9 beta,10 alpha-isomer);

Registry Number MeSH : 2098-66-0;

Related CAS MeSH : 34554-28-4 (Cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer);

Wikipedia link : https://en.wikipedia.org/wiki/Cyproterone;

Is substance : O;

UNII : E61Q31EK2F;

InChIKey : DUSHUSLJJMDGTE-ZJPMUUANSA-N;

Details

Origin ID

D003534;

UMLS CUI

C0010621;

ATC code(s)
- cyproterone and estrogen [ATC Code]
ATC code(s)
- cyproterone [ATC Code]
- cyproterone and estrogen [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- Cyproterone adverse reaction (disorder) [SNOMED CT concept]
Fils d'après SNOMED CT
- androgen antagonists [MeSH Descriptor]
Pharmacological action(s)
- androgen antagonists [MeSH Descriptor]
Record concept(s)
- cyproterone [MeSH concept]
- cyproterone, 1alpha,2 alpha,9 beta,10 alpha-Isomer [MeSH concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Cyproterone [ICD-11 Extension code]
- Cyproterone [NCIt concept]
- Cyproterone (substance) [SNOMED CT concept]
- Product containing cyproterone (medicinal product) [SNOMED CT concept]
- cyproterone [ATC Code]
- cyproterone [SNOMED Notion]
Validated automatic mappings to BTNT
- cyproterone [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients